Publish Date：2026-01-01 00:00:00
Calcium, as the basic element of human life, is closely related to bone health and is more deeply involved in almost all key life processes of the human body. Once insufficient calcium intake is insufficient, it may not only affect physiological function, but also increase the risk of chronic metabolic diseases - calcium deficiency in children is prone to rickets, and calcium deficiency in the elderly may cause osteoporosis, which seriously threatens health.
Therefore, adequate calcium supplementation is crucial for people of all ages, especially children and adolescents in a critical period of growth and development, and adequate calcium intake is the core of supporting growth. However, it should be noted that calcium supplementation is not "more is better", and excessive calcium supplementation may cause side effects, such as increasing the risk of kidney stones and cardiovascular disease. How to scientifically supplement the daily calcium requirement has become a key issue of public concern.
Many people think that drinking milk and eating calcium tablets every day can meet the needs of calcium supplementation, but this is not the case. Traditional calcium carbonate preparations (such as tablets, powders, capsules) have long had pain points of difficult dissolution and low absorption rate, and a large amount of calcium is difficult to be used by the human body, and eventually lost in vain. With the upgrading of calcium supplementation technology, compound calcium carbonate granules have become the current mainstream trend, among which Lizhizhu compound calcium carbonate granules redefine scientific calcium supplementation with innovative technology - it replaces gastric acid with citric acid, achieves rapid in vitro dissolution through patented complexation technology, and directly forms an easily absorbable calcium citrate complex without relying on the body's own stomach acid. This breakthrough not only greatly increases the release rate of calcium ions, but also reduces the irritation of calcium to the gastrointestinal tract. Clinical data show that its calcium absorption rate is 2.5 times that of ordinary calcium carbonate tablets, which really makes calcium supplementation move from "full" to "eat well".
Lizhizhu compound calcium carbonate granules are the core main products of Wuhan Ximo Pharmaceutical Co., Ltd. As an emerging innovation-driven professional pharmaceutical enterprise in China's pharmaceutical industry, Ximo Pharmaceutical has always adhered to the development purpose of "creating high-quality drugs to help bone health", focusing on the treatment of bone-related diseases, innovating and building an integrated R&D model of "clinical-scientific research-information-industry", and is committed to providing patients with breakthrough diagnosis and treatment solutions with bone diseases as the core and extending to other chronic and complex diseases.
The R&D team is well aware that there is a common physiological characteristic of Chinese people: a considerable proportion of people have weak gastric acid secretion. This feature leads to the fact that traditional calcium carbonate (which relies on strong gastric acid decomposition) is like a "stubborn stone", which is difficult to be dissolved and absorbed by the human body, and eventually falls into the dilemma of "supplementing is equivalent to nourishing". To this end, after more than 20 years of painstaking research and development, combined with the genetic inheritance and physical fitness characteristics of Chinese gastric acid secretion, relying on patented technology to successfully create compound calcium carbonate granules, which accurately meet the scientific calcium supplementation needs of Chinese people under the upgrading of consumption.
This product's exclusive patented chelation technology fundamentally resolves the absorption challenges of traditional calcium supplements: it rapidly dissolves outside the body without relying on the body's naturally weak stomach acid, converting into easily absorbed calcium citrate chelates. This breakthrough bypasses the critical “dissolution” hurdle, addressing calcium supplementation pain points for special populations with low stomach acid, such as infants, pregnant women, postpartum mothers, and the elderly. Simultaneously, its patented inclusion complex technology overcomes the issue of vitamin D3's susceptibility to degradation and poor stability in gastric acid, further ensuring calcium supplementation efficacy. Clinically validated, LIZHIZU Compound Calcium Carbonate Granules fully comply with the calcium intake standards recommended by the Chinese Nutrition Society. Each dose precisely matches the calcium requirements of the Chinese population, eliminating the risk of excessive intake at the source. Compared to imported calcium supplements, this product is better suited to the digestive system characteristics of Asians. It is truly a“third-generation intelligent calcium supplementation solution” tailored for Chinese consumers, making calcium supplementation safer, more efficient, and better suited to the constitution of Easterners. In short, Lizhizhu Compound Calcium Carbonate Granules are not a globally applicable “standardized product,” but a scientific achievement developed based on the nutritional characteristics and physiological features of the Chinese population, truly achieving “tailored” scientific calcium supplementation. With years of deep cultivation in the calcium supplementation field, Wuhan Ximo Pharmaceutical Co., Ltd. has accumulated profound technical strength: it holds a total of 32 domestic patents (including 3 valid domestic invention patents and 28 utility model patents), as well as 1 international patent. Leveraging its robust innovation capabilities and R&D achievements, the company has garnered numerous accolades: In December 2020, it was recognized as an “Optics Valley Gazelle Enterprise,” “Science and Technology Small Giant Enterprise,” and “High-Tech Enterprise”; in January 2022, it received the “2021 Hubei Provincial Science and Technology Progress Award”; and in November 2023, it was re-certified as a “High-Tech Enterprise,” continuously demonstrating its strong innovation capabilities. November 2023, it was re-certified as a “High-Tech Enterprise,” consistently demonstrating its robust innovation capabilities.
Health is an essential requirement for promoting the comprehensive development of individuals. In recent years, the nation has vigorously promoted the development of new productive forces in the health industry, encouraged health consumption, and supported enterprises in advancing the construction of “Healthy China.”
LIZHIZU actively responded to the national call, leveraging technological innovation as its core driver. Focusing on the calcium supplementation needs of the populace, it launched its proprietary patented modified innovative drug, Compound Calcium Carbonate Granules. This product successfully filled the gap in high-quality calcium supplementation for special populations in China with insufficient gastric acid secretion, such as infants, young children, and the elderly. It has injected new momentum into China's health industry and contributed to new quality productive forces.
